DrugPatentWatch Database Preview
Organon Usa Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for ORGANON USA INC, and what generic alternatives to ORGANON USA INC drugs are available?
ORGANON USA INC has twenty-four approved drugs.
There are four US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.
There are ninety-three patent family members on ORGANON USA INC drugs in thirty-three countries and twenty-five supplementary protection certificates in nine countries.
Summary for Organon Usa Inc
| International Patents: | 93 |
| US Patents: | 4 |
| Tradenames: | 27 |
| Ingredients: | 22 |
| NDAs: | 24 |
| Patent Litigation for Organon Usa Inc: | See patent lawsuits for Organon Usa Inc |
Drugs and US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | NEXPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-002 | May 31, 2011 | RX | Yes | Yes | 8,722,037 | Start Trial | Y | Start Trial | |||
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-002 | Mar 17, 1994 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Organon Usa Inc | REMERON SOLTAB | mirtazapine | TABLET, ORALLY DISINTEGRATING;ORAL | 021208-001 | Jan 12, 2001 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Organon Usa Inc | MAXIBOLIN | ethylestrenol | TABLET;ORAL | 014005-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Organon Usa Inc | LIQUAEMIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 000552-013 | Apr 11, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-001 | Aug 18, 1999 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Organon Usa Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc | CALDEROL | calcifediol | CAPSULE;ORAL | 018312-002 | Approved Prior to Jan 1, 1982 | 3,565,924 | Start Trial |
| Organon Usa Inc | CALDEROL | calcifediol | CAPSULE;ORAL | 018312-002 | Approved Prior to Jan 1, 1982 | 3,833,622 | Start Trial |
| Organon Usa Inc | RAPLON | rapacuronium bromide | INJECTABLE;INJECTION | 020984-002 | Aug 18, 1999 | 5,418,226 | Start Trial |
| Organon Usa Inc | IMPLANON | etonogestrel | IMPLANT;IMPLANTATION | 021529-001 | Jul 17, 2006 | 4,957,119 | Start Trial |
| Organon Usa Inc | ZEMURON | rocuronium bromide | INJECTABLE;INJECTION | 020214-001 | Mar 17, 1994 | 4,894,369*PED | Start Trial |
| Organon Usa Inc | REMERON | mirtazapine | TABLET;ORAL | 020415-003 | Mar 17, 1997 | 5,977,099 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ORGANON USA INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 250 mcg/0.5 mL, 1 mL PFS | ➤ Subscribe | 2012-03-30 |
International Patents for Organon Usa Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1984063 | Start Trial |
| Japan | 5055501 | Start Trial |
| Norway | 20064716 | Start Trial |
| Taiwan | I434676 | Start Trial |
| Portugal | 1841493 | Start Trial |
| Russian Federation | 2007132008 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Organon Usa Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0303306 | C980027 | Netherlands | Start Trial | PRODUCT NAME: ETONOGESTREL; REGISTRATION NO/DATE: RVG 21168 19980825 |
| 2481400 | 301085 | Netherlands | Start Trial | PRODUCT NAME: CALCIFEDIOL IN IEDERE VORM ZOALS BESCHERMD DOOR HET BASISOCTROOI; NATIONAL REGISTRATION NO/DATE: 124799 20200922; FIRST REGISTRATION: DE 2202115.00.00 20200819 |
| 0136011 | 2000C/027 | Belgium | Start Trial | PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124 |
| 1214076 | SZ 49/2008 | Austria | Start Trial | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON |
| 0771217 | CA 2006 00038 | Denmark | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
| 0303306 | SPC/GB99/044 | United Kingdom | Start Trial | PRODUCT NAME: ETONOGESTREL; REGISTERED: NL RGV21168 19980825; UK 00065/0161 19990609 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
